(Q40936292)

25 September 2017

Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells (English)

1 reference

25 September 2017

Meade-Tollin LC

1

1 reference

25 September 2017

Way D

series ordinal

2

1 reference

25 September 2017

Witte MH

series ordinal

3

1 reference

25 September 2017

1 July 1999

1 reference

25 September 2017

1 reference

25 September 2017

101

1 reference

25 September 2017

3

1 reference

25 September 2017

305-316

1 reference

Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2.

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Constitutive release of metalloproteinase-9 (92-kd type IV collagenase) by Kaposi's sarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Interstitial collagenase is required for angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

1 reference

7 January 2021

KSHV and Kaposi's sarcoma: the end of the beginning?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Herpes-Type Virus Particles in Tissue Culture of Kaposi's Sarcoma From Different Geographic Regions2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Idiopathisches multiples Pigmentsarkom der Haut

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Expression of fibroblast growth factors and their receptors in acquired immunodeficiency syndrome-associated Kaposi sarcoma tissue and derived cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Basic fibroblast growth factor induces angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Kaposi's sarcoma: advances and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Tumor cell interactions with the extracellular matrix during invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Kaposi's sarcoma. A lymphologic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-1281%2899%2980031-2

7 January 2021

10.1016/S0065-1281(99)80031-2

Identifiers

DOI

0 references

1 reference